Articles tagged with Co Receptors
A team of researchers from Tokyo Institute of Technology identified the molecular mechanisms involved in synaptic communication using Drosophila. They found that Side-IV/Beat-IIb immunoglobulin superfamily protein molecules play a crucial role in inducing synapse formation and regulating preferential signaling among neuron pairs.
Mosquitoes use an olfactory coreceptor called Ir8a to detect acidic volatiles found in human sweat, which is necessary for their host detection system. The study suggests new approaches for designing improved mosquito repellents and potentially even a life-saving perfume.
Researchers studied HIV drug combinations to understand why some drugs act synergistically while others do not. They found that virus protein mutations and host cell receptor density affect synergy, highlighting the need for personalized treatment approaches.
Researchers discovered that the protein Pentagone regulates a concentration gradient in the fruit fly wing, controlling vein formation. This mechanism may also be relevant to human development disorders, where it could influence finger formation.
Researchers have determined the high-resolution structure of CCR5, one of two co-receptors used by HIV to enter human cells. The study provides insights into how HIV fuses with cells and may aid in developing new drugs targeting this receptor.
Researchers have determined the high-resolution atomic structure of a cell-surface receptor used by most strains of HIV to infect human immune cells. The study provides detailed insights into how HIV attaches to cells and blocks its entry, guiding the development of next-generation drugs.
Scientists at Rockefeller University have pinpointed DEET's molecular target in insects, showing that the widely used bug repellent acts like a chemical cloak, masking human odors. By targeting specific receptors, DEET confuses mosquitoes and prevents bites.
Researchers describe the interaction between T-cell receptors and coreceptors during an immune response. They found that T-cell receptors and CD8 coreceptors are brought together during antigen sensing, increasing their interaction with endogenous non-stimulatory peptides.
Researchers identified HIV's key molecular site in the brain and colon as CCR5 co-receptor. This finding suggests a potential target for preventing virus entry into these tissues and possibly others.
Researchers have discovered a small peptide called ALX40-4C that blocks the CXCR4 coreceptor used by HIV-1 to infect T cells. This breakthrough suggests a potential new generation of combination therapies that could delay or prevent HIV infection and AIDS progression.
Scientists at Wake Forest University Baptist Medical Center have found a way to inactivate the CCR5 co-receptor, a doorway for early-stage HIV-1 virus, on the surface of macrophages and lymphocytes. This approach could be used to treat early-stage HIV-infected individuals and potentially prevent infection.
Researchers have discovered that different strains of HIV may exploit distinct immune cells through chemokine coreceptors, potentially explaining the sudden collapse of the immune system in full-blown AIDS patients. The findings could lead to new treatments by targeting these receptors.